Cargando…

Individual Burden of Psoriasis (I-BOP): Building and Validation of a New Scoring Tool for Patients with Psoriasis

BACKGROUND: Psoriasis impacts independently of its severity on patients’ lifestyle and quality of life (QoL). AIM: To build a tool for assessing the patient-reported psoriasis burden. METHODS: An expert group created a questionnaire using a standardized methodology building questionnaires assessing...

Descripción completa

Detalles Bibliográficos
Autores principales: Ezzedine, Khaled, Fougerousse, Anne Claire, Aubert, Roberte, Monfort, Jean-Benoît, Reguiaï, Ziad, Shourick, Jason, Taieb, Charles, Maccari, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213973/
https://www.ncbi.nlm.nih.gov/pubmed/32440185
http://dx.doi.org/10.2147/CCID.S249776
_version_ 1783531891613237248
author Ezzedine, Khaled
Fougerousse, Anne Claire
Aubert, Roberte
Monfort, Jean-Benoît
Reguiaï, Ziad
Shourick, Jason
Taieb, Charles
Maccari, François
author_facet Ezzedine, Khaled
Fougerousse, Anne Claire
Aubert, Roberte
Monfort, Jean-Benoît
Reguiaï, Ziad
Shourick, Jason
Taieb, Charles
Maccari, François
author_sort Ezzedine, Khaled
collection PubMed
description BACKGROUND: Psoriasis impacts independently of its severity on patients’ lifestyle and quality of life (QoL). AIM: To build a tool for assessing the patient-reported psoriasis burden. METHODS: An expert group created a questionnaire using a standardized methodology building questionnaires assessing quality of life issues. The questionnaire was translated from French into a cultural and linguistically validated US English version. RESULTS: A conceptual questionnaire of 54 questions was created. The confirmatory analyses resulted in a 10-feature questionnaire divided into 4 internally consistent domains with a Cronbach’s alpha coefficient of 0.9. It was reproducible and highly reliable. It correlated well with the Dermatology Life Quality Index (DLQI), Perceived Stress Scale (PSS), and SF-12 mental and SF12 physical scores. CONCLUSION: This tool allows for the first time to assess the burden of psoriasis patients. Its use may allow improving medical and nonmedical patient care, thus improving their daily life.
format Online
Article
Text
id pubmed-7213973
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-72139732020-05-21 Individual Burden of Psoriasis (I-BOP): Building and Validation of a New Scoring Tool for Patients with Psoriasis Ezzedine, Khaled Fougerousse, Anne Claire Aubert, Roberte Monfort, Jean-Benoît Reguiaï, Ziad Shourick, Jason Taieb, Charles Maccari, François Clin Cosmet Investig Dermatol Methodology BACKGROUND: Psoriasis impacts independently of its severity on patients’ lifestyle and quality of life (QoL). AIM: To build a tool for assessing the patient-reported psoriasis burden. METHODS: An expert group created a questionnaire using a standardized methodology building questionnaires assessing quality of life issues. The questionnaire was translated from French into a cultural and linguistically validated US English version. RESULTS: A conceptual questionnaire of 54 questions was created. The confirmatory analyses resulted in a 10-feature questionnaire divided into 4 internally consistent domains with a Cronbach’s alpha coefficient of 0.9. It was reproducible and highly reliable. It correlated well with the Dermatology Life Quality Index (DLQI), Perceived Stress Scale (PSS), and SF-12 mental and SF12 physical scores. CONCLUSION: This tool allows for the first time to assess the burden of psoriasis patients. Its use may allow improving medical and nonmedical patient care, thus improving their daily life. Dove 2020-05-04 /pmc/articles/PMC7213973/ /pubmed/32440185 http://dx.doi.org/10.2147/CCID.S249776 Text en © 2020 Ezzedine et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Methodology
Ezzedine, Khaled
Fougerousse, Anne Claire
Aubert, Roberte
Monfort, Jean-Benoît
Reguiaï, Ziad
Shourick, Jason
Taieb, Charles
Maccari, François
Individual Burden of Psoriasis (I-BOP): Building and Validation of a New Scoring Tool for Patients with Psoriasis
title Individual Burden of Psoriasis (I-BOP): Building and Validation of a New Scoring Tool for Patients with Psoriasis
title_full Individual Burden of Psoriasis (I-BOP): Building and Validation of a New Scoring Tool for Patients with Psoriasis
title_fullStr Individual Burden of Psoriasis (I-BOP): Building and Validation of a New Scoring Tool for Patients with Psoriasis
title_full_unstemmed Individual Burden of Psoriasis (I-BOP): Building and Validation of a New Scoring Tool for Patients with Psoriasis
title_short Individual Burden of Psoriasis (I-BOP): Building and Validation of a New Scoring Tool for Patients with Psoriasis
title_sort individual burden of psoriasis (i-bop): building and validation of a new scoring tool for patients with psoriasis
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213973/
https://www.ncbi.nlm.nih.gov/pubmed/32440185
http://dx.doi.org/10.2147/CCID.S249776
work_keys_str_mv AT ezzedinekhaled individualburdenofpsoriasisibopbuildingandvalidationofanewscoringtoolforpatientswithpsoriasis
AT fougerousseanneclaire individualburdenofpsoriasisibopbuildingandvalidationofanewscoringtoolforpatientswithpsoriasis
AT aubertroberte individualburdenofpsoriasisibopbuildingandvalidationofanewscoringtoolforpatientswithpsoriasis
AT monfortjeanbenoit individualburdenofpsoriasisibopbuildingandvalidationofanewscoringtoolforpatientswithpsoriasis
AT reguiaiziad individualburdenofpsoriasisibopbuildingandvalidationofanewscoringtoolforpatientswithpsoriasis
AT shourickjason individualburdenofpsoriasisibopbuildingandvalidationofanewscoringtoolforpatientswithpsoriasis
AT taiebcharles individualburdenofpsoriasisibopbuildingandvalidationofanewscoringtoolforpatientswithpsoriasis
AT maccarifrancois individualburdenofpsoriasisibopbuildingandvalidationofanewscoringtoolforpatientswithpsoriasis